Literature DB >> 6476826

Effect of restricted aeration on catabolism of cholic acid by two Pseudomonas species.

M G Smith, R J Park.   

Abstract

Examination of some previously isolated bile acid-utilizing Pseudomonas strains showed that Pseudomonas sp. ATCC 31752, together with other fluorescent strains, can be assigned to Pseudomonas putida biotype B, whereas Pseudomonas sp. ATCC 31753, like most other nonfluorescent strains, is an unrecognized phenotype. A study was made of the growth of these two species at 25 degrees C and pH 7.0 in a fermentor with 2.5 g of sodium cholate liter-1 as sole carbon source, and the catabolism of the cholate and its products was followed by high-pressure liquid chromatographic and thin-layer chromatographic examination. At aeration rates of either 150 or 5 ml min-1 liter-1, growth of each species followed the same catabolic pathway. 7 alpha, 12 beta-Dihydroxy-1,4-androstadiene-3,17-dione was the major catabolite formed, with 0.3 g liter-1 being the maximum concentration that accumulated at the higher aeration rate, whereas 1.4 g liter-1 accumulated at the lower aeration rate, irrespective of the species used. The latter yield is sufficiently high to be of potential commercial value if such a catabolite were found to be economically useful for steroid drug manufacture. It is postulated that the rate-limiting step in cholic acid catabolism by these species at the lower aeration rate is 9 alpha-hydroxylation, a step requiring molecular oxygen, hence, the marked effect of oxygen limitation on catabolite accumulation. Another consequence of oxygen limitation is the production of a red pigment in the culture medium, which, however, does not affect catabolite recovery.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476826      PMCID: PMC240328          DOI: 10.1128/aem.48.1.108-113.1984

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  10 in total

1.  Two simple media for the demonstration of pyocyanin and fluorescin.

Authors:  E O KING; M K WARD; D E RANEY
Journal:  J Lab Clin Med       Date:  1954-08

2.  The degradation of chenodeoxycholic acid by Pseudomonas Spp. N.C.I.B. 10590.

Authors:  M E Tenneson; J D Baty; R F Bilton; A N Mason
Journal:  J Steroid Biochem       Date:  1979-03       Impact factor: 4.292

3.  A numerical taxonomic study of Pseudomonas strains from spoiled meat.

Authors:  B G Shaw; J B Latty
Journal:  J Appl Bacteriol       Date:  1982-04

4.  The major neutral products of the aerobic catabolism of cattle bile by Pseudomonas sp. ATCC 31752.

Authors:  R J Park
Journal:  Steroids       Date:  1981-10       Impact factor: 2.668

5.  The aerobic pseudomonads: a taxonomic study.

Authors:  R Y Stanier; N J Palleroni; M Doudoroff
Journal:  J Gen Microbiol       Date:  1966-05

6.  The degradation of cholic acid by Pseudomonas sp. N.C.I.B. 10590.

Authors:  M E Tenneson; J D Baty; R F Bilton; A N Mason
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

7.  Deoxycholic acid degradation by a Pseudomonas sp. Acidic intermediates with A-ring unsaturation.

Authors:  R A Leppik
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

8.  Deoxycholic acid degradation by a Pseudomonas species. Acidic intermediates from the initial part of the catabolic pathway.

Authors:  R A Leppik
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

9.  17 alpha-alkynyl-11 beta, 17-dihydroxyandrostane derivatives : a new class of potent glucocorticoids.

Authors:  G Teutsch; G Costerousse; R Deraedt; J Benzoni; M Fortin; D Philibert
Journal:  Steroids       Date:  1981-12       Impact factor: 2.668

10.  Aerobic catabolism of bile acids.

Authors:  R A Leppik; R J Park; M G Smith
Journal:  Appl Environ Microbiol       Date:  1982-10       Impact factor: 4.792

  10 in total
  1 in total

1.  Pseudomonas mutant strains that accumulate androstane and seco-androstane intermediates from bile acids.

Authors:  R A Leppik; D J Sinden
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.